Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,241 | -10,814 | N/A | -22,532 | -13,241 |
| Depreciation Amortization | 398 | 196 | N/A | 518 | 327 |
| Accounts payable and accrued liabilities | 446 | 35 | N/A | 133 | -558 |
| Other Working Capital | 7,134 | 6,336 | N/A | -13,091 | -8,203 |
| Other Operating Activity | 1,723 | 659 | 0 | 2,774 | 2,586 |
| Operating Cash Flow | $-11,540 | $-3,588 | $N/A | $-32,198 | $-19,089 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -22 | N/A | -212 | -212 |
| Purchase Of Investment | -19,342 | -9,807 | N/A | -45,114 | -42,561 |
| Sale Of Investment | 31,261 | 15,342 | N/A | 52,052 | 39,729 |
| Investing Cash Flow | $11,884 | $5,513 | $N/A | $6,726 | $-3,044 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -53 | -54 |
| Common Stock Issued | 106 | 46 | N/A | 11,636 | 11,592 |
| Financing Cash Flow | $106 | $46 | $N/A | $11,583 | $11,538 |
| Exchange Rate Effect | -65 | 254 | N/A | 498 | 308 |
| Beginning Cash Position | 15,789 | 15,789 | N/A | 32,006 | 32,006 |
| End Cash Position | 16,174 | 18,014 | N/A | 18,615 | 21,719 |
| Net Cash Flow | $385 | $2,225 | $N/A | $-13,391 | $-10,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,540 | -3,588 | N/A | -32,198 | -19,089 |
| Capital Expenditure | -35 | -22 | N/A | -212 | -212 |
| Free Cash Flow | -11,575 | -3,610 | 0 | -32,410 | -19,301 |